Visit website
CARE

Investment June 2012

SectorHealthcare and Life Sciences

Business Fertility Services

Growth StrategyBuy-and-BuildRoll-Out

Why we invested

Due to declining fertility rates and other lifestyle factors, CARE Fertility operates in a growing market. The company is the clear market leader with an outstanding reputation based on its superior success rates and clinical leadership. This was an opportunity to back a management team with an unrivalled track record, to expand through the roll-out and acquisition of new clinics.

Care facilities

22

The result

During Bowmark’s period of investment, CARE expanded its operations, adding clinics in London, Tunbridge Wells, Bath, Birmingham and Dublin, through the development and acquisition of new sites and investment in existing facilities. The company also remained at the forefront of new clinical technology, including developing the time lapse embryo imaging technique, CAREmaps.

In 2019, CARE Fertility was sold to Silverfleet Capital for an undisclosed sum.

Bowmark get it. They really understand our business and our industry and have helped us to realise our objectives. The experience has been a very positive one. Simon Fishel,Chief Executive

Read more about our Healthcare and Life Sciences strategy

Find out more